Daily Archives: July 5, 2013

Featured Stories
FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Investigation Launched over California Fireworks Display that Injured Dozens

fireworks_accident_injuries

Dozens of people were injured when a fireworks display went awry in Simi Valley, California, Reuters reports. At first, Simi Valley police said that 28 people were hurt by the incident but calls to local hospitals suggest that at least … Continue reading

Posted in Legal News |

Some Tamoxifen Side Effects Explained

tamoxifen

Research has revealed why tamoxifen protects against breast cancer, yet increases risks for uterine cancer. Tamoxifen is used to prevent the return of estrogen-dependent breast tumors. Tamoxifen blocks estrogen action in the breast, slowing or preventing breast cancer in many … Continue reading

Posted in Pharmaceuticals |

Do Consumers Know the Risks of Medtronic InFuse? Are Consumers Aware of Safer Options?

medtronic_infuse_danger_alternatives

Medtronic’s bone graft product, InFuse, is a synthetic, or genetically engineered, recombinant human Bone Morphogenetic Protein (rhBMP-2) that was approved by the U.S. Food & Drug Administration (FDA) in 2002 for specific uses. Meant to stimulate spine growth in patients … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.